Trexquant Investment LP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,762,162
+83.1%
157,084
+43.9%
0.10%
+76.8%
Q1 2023$2,055,088
+28.1%
109,197
+8.3%
0.06%
+24.4%
Q4 2022$1,604,545
+106.2%
100,788
+111.8%
0.04%
+66.7%
Q3 2022$778,000
-67.4%
47,580
-51.8%
0.03%
-75.9%
Q1 2022$2,388,000
+501.5%
98,612
+312.6%
0.11%
+250.0%
Q3 2021$397,000
-58.9%
23,902
-39.7%
0.03%
-61.0%
Q2 2021$967,000
-24.0%
39,634
+66.6%
0.08%
-39.3%
Q4 2020$1,272,000
+68.9%
23,797
+30.4%
0.14%
+181.2%
Q3 2020$753,000
+2.4%
18,245
+20.3%
0.05%
-5.9%
Q2 2020$735,000
-1.7%
15,168
-14.3%
0.05%
-5.6%
Q1 2020$748,000
-81.1%
17,696
-80.8%
0.05%
-76.9%
Q4 2019$3,950,000
+347.8%
92,341
+276.9%
0.23%
+207.9%
Q3 2019$882,000
+38.9%
24,497
+3.1%
0.08%
+33.3%
Q2 2019$635,000
-21.8%
23,756
-21.4%
0.06%
-1.7%
Q1 2019$812,000
+23.2%
30,237
-25.8%
0.06%
+41.5%
Q4 2018$659,000
+52.5%
40,759
+44.1%
0.04%
+36.7%
Q2 2018$432,000
-63.0%
28,281
-45.5%
0.03%
-63.0%
Q1 2018$1,167,00051,9300.08%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders